381 related articles for article (PubMed ID: 16091868)
1. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
2. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
3. A risk-stratified approach to prostate-specific antigen screening.
Keto CJ; Freedland SJ
Eur Urol; 2011 Apr; 59(4):506-8. PubMed ID: 21292387
[No Abstract] [Full Text] [Related]
4. [PSA related screening of prostate cancer. Panic or improvement?].
Fornara P; Jurczok A
Aktuelle Urol; 2004 Feb; 35(1):43-8. PubMed ID: 14997414
[TBL] [Abstract][Full Text] [Related]
5. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
6. Prostate cancer: screening and early detection.
Tariman JD
Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
[No Abstract] [Full Text] [Related]
7. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
8. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
9. Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam.
Bul M; van Leeuwen PJ; Zhu X; Schröder FH; Roobol MJ
Eur Urol; 2011 Apr; 59(4):498-505. PubMed ID: 21334136
[TBL] [Abstract][Full Text] [Related]
10. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing.
Oberaigner W; Horninger W; Klocker H; Schönitzer D; Stühlinger W; Bartsch G
Am J Epidemiol; 2006 Aug; 164(4):376-84. PubMed ID: 16829552
[TBL] [Abstract][Full Text] [Related]
11. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
12. AUA issues a policy report on PSA monitoring. The American Urological Association.
Scott Morey S
Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
[No Abstract] [Full Text] [Related]
13. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
14. Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials.
Collette L
Eur Urol; 2008 Jan; 53(1):6-9. PubMed ID: 17764823
[No Abstract] [Full Text] [Related]
15. Can we accurately identify men with low risk prostate cancer?
Neal DE
J Urol; 2008 Oct; 180(4):1217-8. PubMed ID: 18707718
[No Abstract] [Full Text] [Related]
16. [The prostate specific antigen: what can we learn from the American experience?].
Zhao XJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
[No Abstract] [Full Text] [Related]
17. Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.
van Gils MP; Stenman UH; Schalken JA; Schröder FH; Luider TM; Lilja H; Bjartell A; Hamdy FC; Pettersson KS; Bischoff R; Takalo H; Nilsson O; Mulders PF; Bangma CH
Eur Urol; 2005 Dec; 48(6):1031-41. PubMed ID: 16054748
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer--more information and more questions.
Dall'Era M; Carroll PR
J Urol; 2007 May; 177(5):1607-8. PubMed ID: 17437768
[No Abstract] [Full Text] [Related]
19. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
20. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
[Next] [New Search]